John B Welsh

Summary

Affiliation: Medtronic Inc
Country: USA

Publications

  1. ncbi Insights from a large observational database of continuous glucose monitoring adoption, insulin pump usage and glycemic control: the CareLink™ database
    John B Welsh
    Medtronic, Inc, 18000 Devonshire Street, Northridge, CA 91325, USA
    Pediatr Endocrinol Rev 7:413-6. 2010
  2. ncbi Usage and effectiveness of the low glucose suspend feature of the Medtronic Paradigm Veo insulin pump
    Pratik Agrawal
    Medtronic, Inc, Northridge, California 91325, USA
    J Diabetes Sci Technol 5:1137-41. 2011
  3. ncbi Practical considerations in the use of real-time continuous glucose monitoring alerts
    John Mastrototaro
    Medtronic Diabetes, Northridge, California 91325, USA
    J Diabetes Sci Technol 4:733-9. 2010
  4. ncbi Designing the modern pump: engineering aspects of continuous subcutaneous insulin infusion software
    John B Welsh
    Diabetes, Medtronic Inc, 18000 Devonshire Street, Northridge, CA 91325, USA
    Diabetes Technol Ther 12:S37-42. 2010

Collaborators

Detail Information

Publications4

  1. ncbi Insights from a large observational database of continuous glucose monitoring adoption, insulin pump usage and glycemic control: the CareLink™ database
    John B Welsh
    Medtronic, Inc, 18000 Devonshire Street, Northridge, CA 91325, USA
    Pediatr Endocrinol Rev 7:413-6. 2010
    ..This study examined CGM usage and its relationship to insulin delivery and glycemia in CareLink users with type 1 diabetes mellitus (T1DM)...
  2. ncbi Usage and effectiveness of the low glucose suspend feature of the Medtronic Paradigm Veo insulin pump
    Pratik Agrawal
    Medtronic, Inc, Northridge, California 91325, USA
    J Diabetes Sci Technol 5:1137-41. 2011
    ..The Medtronic Paradigm® Veo™ pump with automatic low glucose suspend (LGS) was released in 2009. Data from 7 months of real-world use of the system were analyzed to assess usage patterns and effectiveness of LGS...
  3. ncbi Practical considerations in the use of real-time continuous glucose monitoring alerts
    John Mastrototaro
    Medtronic Diabetes, Northridge, California 91325, USA
    J Diabetes Sci Technol 4:733-9. 2010
    ..Real-time CGM is safe and generally well tolerated; however, individualization of alert settings is necessary maximize the system's benefits and patient adherence...
  4. ncbi Designing the modern pump: engineering aspects of continuous subcutaneous insulin infusion software
    John B Welsh
    Diabetes, Medtronic Inc, 18000 Devonshire Street, Northridge, CA 91325, USA
    Diabetes Technol Ther 12:S37-42. 2010
    ..In particular, pumps that are combined with glucose sensors and appropriate algorithms will provide the basis for increasingly safe and precise automated insulin delivery-essential steps to developing a fully closed-loop system...